期刊文献+

饮酒与前列腺癌危险性关系的随访研究 被引量:1

Alcohol and prostate cancer in the NHANES Ⅰ:An epidemiologic follow-up study
下载PDF
导出
摘要 目的对酒精的消费与前列腺癌的关系进行了随访研究。方法本研究为前瞻性的随机对照研究。研究对象根据年龄分为二个队列。队列1:从1991~1995年开始,包括了5766例男性,年龄25~74岁,平均随访时间为17年。队列2:从队列1抽取研究对象,从2002年开始到2004年,包括了3775例研究对象,平均随访时间9年。酒精消费的计算基线为患者平日的饮酒量,既往饮酒史为患者25、35、45和55岁饮酒情况。结果总共发生了254例前列腺肿瘤,与以前的大多数研究结果一致,酒精总的饮用量与前列腺癌没有明显关系(P〉0.05),但在第2队列中,重度饮酒和前列腺癌之间存在逆相关[(RR)=0.23,95%CI=0.06~0.95],进一步研究发现;既往在25岁、35岁、45岁有大量饮酒的患者(每周〉25次),与前列腺癌的发生逆相关。结论研究结果说明既往有大量饮酒史与前列腺癌发生有关。 Objective We prospectively investigated the association between alcohol consumption and prostate cancer in the epidemiologic followup study (NHEFS) of the first National Health and Nutrition Examination Survey (NHANES I)o Methods There were two cohorts: 1) Cohort I, followed from baseline (1991 to 1995) through 2002, included 5766 men ages 25-74 years (median follow-up-17 years); and 2) Cohort Ⅱ, followed from the first follow-up round for Cohort I (2002 to 2004) through 2002, included the 3775 men in Cohort I free of prostate cancer in 2002 to 2004 (median follow-up9 years). Alcohol consumption was assessed at baseline as usual consumption, and at follow-up as usual consumption and as distant past consumption at the ayes of 25, 35, 45, and 55. Results There were 254 incident cases of prostate cancer. Consistent with most previous studies,we found no significant associations between usual total alcohol consumption and prostate cancer in Cohorts I or Ⅱ [p=non significant (NS)], except for a significant inverse association at the heaviest level of drinking in Cohort Ⅱ [relative risk (RR)=0.23, 95% confidence interval (CI=0.06-0.95] further study of heavy drinkers in Cohort 11 revealed significant inverse associations between distant past heavy drinking (defined as〉25 drinks/week) and prostate cancer at age 25 (RR = 0.20, 95% CI=0.06-0.63), age 35 (RR=0.30, 95% CI=0.12-0.77), and age 45 (RR = 0.39, 95% CI = 0.17-0.93), but not at age 55 (RR = 0.43, 95% CI=0.17-1.10). Conclusion These results suggest that it may be important to consider distant past consumption in etiologic studies of prostate cancer. However, our results were based nn small alcohol numbers and require replication.
作者 薛川
出处 《中国现代医生》 2012年第13期44-47,共4页 China Modern Doctor
关键词 酒精 前列腺癌 队列研究 Alcohol Prostate cancer Cohort study
  • 相关文献

参考文献12

  • 1Tsujimura A,Takao T,Okuda H,et al. Survey of lower urinary tractsymptoms in patients with benign prostatic hyperplasia and usefulness of tamsulosin hydrochloride[J]. Urol Surg, 2010,23 ( 11 ) : 301-308.
  • 2Homma Y,Kakizaki H,Yamaguchi O,et al." Assessment of overactive bladder symptoms: comparison of 3-day bladder diary and the overac- tive bladder symptoms score[J]. Urology,2011,77(9) :60-64.
  • 3叶定伟,李长岭.前列腺癌发病趋势的回顾和展望[J].中国癌症杂志,2007,17(3):177-180. 被引量:119
  • 4Sonoda T,Nagata Y,Mori M,et al. A case-control study of diet and prostate cancer in Japan: possible protective effect of traditional Japanese diet[J]. Cancer Sci, 2004,95 (3) : 238-242.
  • 5Yegnasubramanian S, Kowalski J,Gonzalgo ML,et al. Hypermethylation of CpG islands in primary and metastatic human prostate cancer [J]. Cancer Res,2004,64(6) : 1975-1986.
  • 6ZuK,Giovannucci E. Smoking and aggressive prostate:a review of the epidemiologic evidence[J]. Cancer Causes Control,2009,20(10):1799- 1810.
  • 7Bagllotto L,Severi G,English DR,et al. Alcohol consumption and prostate cancer risk:Results from the Melbourne collaborative cohort study[J]. Int J Cancer,2006,119(6) : 1501-1504.
  • 8Middleton Fillmore K, Chikritzhs T, Stockwe11 T, et al. Alcohol use and prostate cancer: a meta-analysis [J]. Mol Nutr Food Res,2009,53 (2) :240-255.
  • 9李珲,辛殿祺,那彦群.肾上腺分泌雄激素与前列腺癌[J].国际泌尿系统杂志,2006,26(2):207-210. 被引量:3
  • 10施侣元,仇成轩.前列腺癌流行病学研究进展[J].中国热带医学,2001,1(1):50-53. 被引量:7

二级参考文献35

  • 1邵常霞,项永兵,刘振伟,高静,孙璐,方茹蓉,阮志贤,高立峰,金凡,高玉堂.上海市区泌尿系统恶性肿瘤相对生存率分析[J].中国肿瘤临床,2005,32(6):321-324. 被引量:31
  • 2叶定伟.前列腺癌的流行病学和中国的发病趋势[J].中华外科杂志,2006,44(6):362-364. 被引量:168
  • 3Prostate Cancer Trialists ' Collaborative Group. Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials. Lancet,2000,355 : 1491 - 1498.
  • 4Crawford ED, Eisenberger MA, McLeod DG, et al. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Engl J Med,1989,321:419 - 424.
  • 5Eisenberger MA, Blumenstein BA, Crawford ED, et al. Bilateral orchiectomy with or without flutamide for metastatic prostate cancer. N Engl J Med,1998,339 : 1036 - 1042.
  • 6Keller ET, Ershler WB, Chang C. The androgen receptor: a mediator of diverse responses. Front Biosci 1996 ; 1 ( 1 ) :d59 - 71.
  • 7Guo Z, Benten WP, Krucken J, Wundcrlich F. Nongenomic testosterone calcium signaling. Genotropic actions in androgen receptor - free macrophages. J Biol Chem,2002,277 ( 33 ) :29600 - 7.
  • 8Losel RM, Falkenstein E, Feuring M, Schultz A, Tillmann HC, Rossol - Haseroth K, et al. Nongenomic steroid action: controversies,questions, and answers. Physiol Rev,2003,83(3) :965-1016.
  • 9Benten WPM, Lieberherr M, Stamm O, Wrehlke C, Guo Z,Wunderlich F. Testosterone signaling through intemalizable surface receptors in androgen receptor - free macrophages. Mol Biol Cell, 1999, 10(10) :3113-23.
  • 10Berthon P, Waller AS, Villette JM, Lofidon L, Cussenot O, Maitland NJ. Androgens are not a direct requirement for the proliferation of human prostatic epithelium in vitro. Int J Cancer, 1997,73 ( 6 ) : 910-6.

共引文献126

同被引文献13

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部